If you want to understand why Canadian corporations are buying German cannabis companies – read this carefully.
The merger of Sanity Group with Organigram Global shows:
Germany is no longer a future market.
Germany is an acquisition market.
Here is exactly what buyers from Canada are looking for:
1️⃣ Regulatory substance
Pharmacy access.
GMP structures.
Robust compliance.
Not hype – but structure.
2️⃣ Integrable value creation
Production + distribution + brand = valuation lever.
Those who can dock on vertically become strategically relevant.
3️⃣ Predictable scaling
Earnout structures show:
Buyers pay for performance – not just vision.
If you can show that your model is replicable, your multiple rises.
Canadian players bring capital, cultivation expertise and capital-market access.
German companies bring the market, regulation and pharmacy infrastructure.
This is no coincidence.
This is strategic complementarity.
This is how you become exit-ready:
- Clean governance
- Clear KPIs
- Documented processes
- Integration possible without chaos
And above all: a story that makes sense from the buyer's perspective.
💬 Would your company pass the due diligence of a Canadian corporation today?
If you want to find out, call me at +4995191279102 or message me "Exit" on WhatsApp at +491621512252.